Chemoinformaics analysis of 2-Methylbutyl butyrate
| Molecular Weight | 158.241 | nRot | 5 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 1 |
| Exact Molecular Weight | 158.131 | nRing | 0 |
| Solubility: LogS | -2.798 | nHRing | 0 |
| Solubility: LogP | 3.274 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.6363 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.574 |
| Synth | 2.467 |
| Natural Product Likeliness | 0.606 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.332 |
| MDCK | 0.0000278 |
| BBB | 0.968 |
| PPB | 0.778868 |
| VDSS | 0.632 |
| FU | 0.257842 |
| CYP1A2-inh | 0.876 |
| CYP1A2-sub | 0.458 |
| CYP2c19-inh | 0.336 |
| CYP2c19-sub | 0.78 |
| CYP2c9-inh | 0.222 |
| CYP2c9-sub | 0.437 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.212 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.24 |
| CL | 12.077 |
| T12 | 0.839 |
| hERG | 0.029 |
| Ames | 0.01 |
| ROA | 0.068 |
| SkinSen | 0.874 |
| Carcinogencity | 0.348 |
| EI | 0.973 |
| Respiratory | 0.22 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.94498 |